Hereditary transthyretin‐related amyloidosis. (23rd October 2018)

• Record Type: Journal Article
• Authors: Finsterer, Josef; Iglseder, Stephan; Wanschitz, Julia; Topakian, Raffi; Löscher, Wolfgang N.; Grisold, Wolfgang
• Is Part Of: Acta neurologica Scandinavica. Volume 139:Number 2(2019)
• Page Start: 92
• Page End: 105
• Publication Date: 2018-10-23
• Subjects: amyloid -- neuropathy -- small fiber -- tafamidis -- transplantation -- transthyretin; Neurology -- Periodicals; 616.8
• DOI: 10.1111/ane.13035
• Languages: English
• ISSNs: 0001-6314

Abstract

Abstract : Hereditary transthyretin(TTR)‐related amyloidosis (ATTRm amyloidosis) is an endemic/non‐endemic, autosomal‐dominant, early‐ and late‐onset, rare, progressive disorder, predominantly manifesting as length‐dependent, small fiber dominant, axonal polyneuropathy and frequently associated with cardiac disorders and other multisystem diseases. ATTRm amyloidosis is due to variants in the TTR gene, with the substitution Val30Met as the most frequent mutation. TTR mutations lead to destabilization and dissociation of TTR tetramers into variant TTR monomers, and formation of amyloid fibrils, which are consecutively deposited extracellularly in various tissues, such as nerves, heart, brain, eyes, intestines, kidneys, or the skin. Neuropathy may not only include large nerve fibers but also small fibers, and not only sensory and motor fibers but also autonomic fibers. Types of TTR variants, age at onset, penetrance, and clinical presentation vary between geographical areas. Suggestive of a ATTRm amyloidosis are a sensorimotor polyneuropathy, positive family history, autonomic dysfunction, cardiomyopathy, carpal tunnel syndrome, unexplained weight loss, and resistance to immunotherapy. If only sensory A‐delta or C fibers are affected, small fiber neuropathy ensues. Diagnostic tests for small fiber neuropathy include determination of intraepidermal nerve fiber density, laser‐evoked potentials, heat‐ and cold‐detection thresholds, and measurement of the electrochemical skin conductance. Therapy currently relies on liver transplantation and TTR‐stabilizers (tafamidis, diflunisal).